Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

FGEN Fibrogen Inc

Price (delayed)

$0.2876

Market cap

$29.06M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.1

Enterprise value

$128.04M

FibroGen, Inc. is a biopharmaceutical company committed to discovering, developing, and commercializing a pipeline of first-in-class therapeutics. The Company applies its pioneering expertise in hypoxia-inducible factor (HIF) and connective tissue ...

Highlights
The net income has surged by 96% year-on-year and by 79% since the previous quarter
The company's EPS has surged by 96% YoY and by 79% QoQ
The quick ratio has plunged by 58% YoY but it has grown by 21% from the previous quarter
FGEN's gross profit has dropped by 197% since the previous quarter and by 196% year-on-year
The company's revenue has shrunk by 179% QoQ and by 165% YoY

Key stats

What are the main financial stats of FGEN
Market
Shares outstanding
101.04M
Market cap
$29.06M
Enterprise value
$128.04M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
N/A
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
-$23.54M
Gross profit
-$13.6M
Operating income
-$134.27M
Net income
-$10.01M
EBIT
-$4.8M
EBITDA
-$2.6M
Free cash flow
-$75.2M
Per share
EPS
-$0.1
EPS diluted
-$0.1
Free cash flow per share
-$0.74
Book value per share
-$2.15
Revenue per share
-$0.23
TBVPS
$1.64
Balance sheet
Total assets
$165.21M
Total liabilities
$340.14M
Debt
$132.59M
Equity
-$216.9M
Working capital
$75.14M
Liquidity
Debt to equity
-0.61
Current ratio
2.02
Quick ratio
0.46
Net debt/EBITDA
-38.05
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-4.3%
Return on equity
N/A
Return on invested capital
-3%
Return on capital employed
-5.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

FGEN stock price

How has the Fibrogen stock price performed over time
Intraday
-9.59%
1 week
-12.85%
1 month
-14.91%
1 year
-74.99%
YTD
-45.68%
QTD
-7.2%

Financial performance

How have Fibrogen's revenue and profit performed over time
Revenue
-$23.54M
Gross profit
-$13.6M
Operating income
-$134.27M
Net income
-$10.01M
Gross margin
N/A
Net margin
N/A

FGEN financials

FGEN's gross profit has dropped by 197% since the previous quarter and by 196% year-on-year
The company's revenue has shrunk by 179% QoQ and by 165% YoY
The net income has surged by 96% year-on-year and by 79% since the previous quarter
FGEN's operating income has surged by 55% year-on-year and by 11% since the previous quarter

Price vs fundamentals

How does FGEN's price correlate with its fundamentals

FGEN Price vs fundamentals

FGEN Earnings waterfall

FGEN Price vs fair value

Growth

What is Fibrogen's growth rate over time

FGEN growth chart

Valuation

What is Fibrogen stock price valuation
P/E
N/A
P/B
N/A
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A

Valuation vs average

Price to earnings (P/E)

The company's EPS has surged by 96% YoY and by 79% QoQ

Price to book (P/B)

FGEN's equity is up by 4.9% year-on-year and by 3.9% since the previous quarter

Price to sales (P/S)

The company's revenue has shrunk by 179% QoQ and by 165% YoY

Efficiency

How efficient is Fibrogen business performance
FGEN's return on invested capital has surged by 96% year-on-year and by 87% since the previous quarter
FGEN's return on assets has surged by 92% year-on-year and by 74% since the previous quarter

Dividends

What is FGEN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for FGEN.

Financial health

How did Fibrogen financials performed over time

Assets vs liabilities

FGEN's total assets is 51% smaller than its total liabilities
The quick ratio has plunged by 58% YoY but it has grown by 21% from the previous quarter
FGEN's total assets has dropped by 55% year-on-year and by 23% since the previous quarter

Debt vs equity

The company's debt is 161% higher than its equity
The company's debt fell by 34% YoY
FGEN's debt to equity is up by 31% YoY but it is down by 5% from the previous quarter

Balance sheet

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.